Results 71 to 80 of about 691 (170)
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997-2022: Data From the Icona Cohort. [PDF]
Open Forum Infect DisGiacomelli A, Lanini S, De Vito A, De Benedittis S, Mazzitelli M, Ceccarelli M, Gagliardini R, Madeddu G, Quiros-Roldan E, Girardi E, Checchi D, Lapadula G, Tascini C, Tavelli A, Antinori A, d'Arminio Monforte A. +15 moreeuropepmc +1 more sourceEffectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort. [PDF]
J Antimicrob ChemotherVergori A, Cozzi-Lepri A, Lo Caputo S, Tavelli A, Mazzotta V, Schiaroli E, Orofino G, Mussini C, Nozza S, Cingolani A, Antinori A, d'Arminio Monforte A, Icona Foundation Study Group. +12 moreeuropepmc +1 more sourceTrends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV. [PDF]
Cancers (Basel), 2023 Greenberg L, Ryom L, Bakowska E, Wit F, Bucher HC, Braun DL, Phillips A, Sabin C, d'Arminio Monforte A, Zangerle R, Smith C, De Wit S, Bonnet F, Pradier C, Mussini C, Muccini C, Vehreschild JJ, Hoy J, Svedhem V, Miró JM, Wasmuth JC, Reiss P, Llibre JM, Chkhartishvili N, Stephan C, Hatleberg CI, Neesgaard B, Peters L, Jaschinski N, Dedes N, Kuzovatova E, Van Der Valk M, Menozzi M, Lehmann C, Petoumenos K, Garges H, Rooney J, Young L, Lundgren JD, Bansi-Matharu L, Mocroft A, On Behalf Of The Respond And D A D Study Groups. +41 moreeuropepmc +1 more sourceEffectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort. [PDF]
J Antimicrob ChemotherGagliardini R, De Benedittis S, Tavelli A, Lapadula G, Mazzotta V, Bruzzesi E, Cervo A, Carrozzo G, Saracino A, Rusconi S, Marchetti G, Ceccherini-Silberstein F, Antinori A, d'Arminio Monforte A, Muccini C, Icona Foundation Study Group
. +15 moreeuropepmc +1 more sourceFacciamo Luce
And
Il saggio analizza l’affermazione della luce elettrica tra fine Ottocento e prima metà del Novecento attraverso i manifesti pubblicitari dedicati a lampade e sistemi di illuminazione.Marcello Scalzodoaj Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in Italy. [PDF]
J Antimicrob ChemotherCozzi-Lepri A, Tavelli A, Taramasso L, Lapadula G, Bobbio N, Piconi S, Guaraldi G, Di Biagio A, Castagna A, Mazzotta V, d'Arminio Monforte A, Icona Foundation Study group
. +11 moreeuropepmc +1 more sourceMortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. [PDF]
Cancers (Basel)Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Bonnet F, Lundgren J, Bottanelli M, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L, On Behalf Of The D A D And Respond Study Groups. +25 moreeuropepmc +1 more sourceRisk of Cancer in People With HIV Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years: An International, Multicenter, Observational Cohort. [PDF]
Clin Infect DisHan WM, Ryom L, Sabin CA, Greenberg L, Cavassini M, Egle A, Duvivier C, Wit FWNM, Mussini C, d'Arminio Monforte A, Castagna A, Miro JM, van der Valk M, Bonnet F, Pradier C, Skocic M, Matulionyte R, Stöckle M, Jaschinski N, Timiryasova A, Tallada J, Rogatto FP, Vannappagari V, Young LA, Lundgren JD, Petoumenos K, Hoy JF. +26 moreeuropepmc +1 more source